Outlook Therapeutics, Inc.
NASDAQOTLK short interest jumped 27.5% over one week to 16.7% of float, driven by biotech sector weakness ahead of earnings today.
Snapshot as of 14 May 2026
Outlook Therapeutics heads into its May 14 results carrying a short position that has exploded from the fringes to become a defining feature of the stock. The short build is the standout heading into today's print.…
Outlook Therapeutics heads into its fiscal Q2 earnings release tomorrow — May 14 — with short sellers having tripled their position in six weeks and the options market tilting heavily toward calls. Short interest has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OTLK — free to start on ORTEX.
Sign up for free →Open OTLK on ORTEX